AIG
ADVM

American International Group’s Adverum Biotechnologies ADVM Stock Holding History

American International Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,313
Closed -$57K – 3086
2022
Q1 		$57K Sell
4,313
-304
-7% -$4.45K ﹤0.01% 2799
2021
Q4 		$81K Sell
4,617
-138
-3% -$2.76K ﹤0.01% 2811
2021
Q3 		$103K Sell
4,755
-113
-2% -$2.88K ﹤0.01% 2793
2021
Q2 		$170 Sell
4,868
-320
-6% -$17.2K ﹤0.01% 2612
2021
Q1 		$512 Buy
5,188
+14
+0.3% +$1.68K ﹤0.01% 1826
2020
Q4 		$561 Sell
5,174
-21
-0.4% -$2.6K ﹤0.01% 1688
2020
Q3 		$535K Buy
5,195
+729
+16% +$109K ﹤0.01% 1562
2020
Q2 		$933K Buy
4,466
+723
+19% +$128K ﹤0.01% 1261
2020
Q1 		$366K Buy
3,743
+363
+11% +$42.3K ﹤0.01% 1578
2019
Q4 		$389K Sell
3,380
-29
-0.9% -$2.56K ﹤0.01% 1834
2019
Q3 		$186K Buy
3,409
+31
+0.9% +$3.49K ﹤0.01% 2212
2019
Q2 		$402K Sell
3,378
-94
-3% -$7.78K ﹤0.01% 1820
2019
Q1 		$182K Sell
3,472
-112
-3% -$4.53K ﹤0.01% 2260
2018
Q4 		$113K Sell
3,584
-28
-0.8% -$1.14K ﹤0.01% 2525
2018
Q3 		$219K Buy
3,612
+65
+2% +$3.65K ﹤0.01% 2370
2018
Q2 		$188K Buy
+3,547
New +$213K ﹤0.01% 2389
2017
Q2 		– Sell
-1,416
Closed -$38K – 3076
2017
Q1 		$38K Buy
1,416
+93
+7% +$2.65K ﹤0.01% 2893
2016
Q4 		$38K Sell
1,323
-3
-0.2% -$98 ﹤0.01% 2908
2016
Q3 		$54.5K Buy
1,326
+2
+0.2% +$76 ﹤0.01% 2878
2016
Q2 		$41.8K Buy
1,324
+179
+16% +$8.09K ﹤0.01% 2986
2016
Q1 		$59K Hold
1,145
– – ﹤0.01% 3773
2015
Q4 		$109K Sell
1,145
-2
-0.2% -$176 ﹤0.01% 3419
2015
Q3 		$95K Buy
1,147
+1
+0.1% +$128 ﹤0.01% 3521
2015
Q2 		$186K Buy
1,146
+712
+164% +$240K ﹤0.01% 3075
2015
Q1 		$176K Hold
434
– – ﹤0.01% 3075
2014
Q4 		$234K Buy
+434
New +$167K ﹤0.01% 2812

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

American International Group's ADVM Position: Q2 2022 in Review

American International Group sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 4,313 shares — an estimated $57K sold.

American International Group first reported a position in ADVM in Q4 2014 and held it in 26 quarters. The position peaked at $933K in Q2 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • American International Group reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 4,313 Adverum Biotechnologies shares in Q2 2022, an estimated $57K.
  • American International Group first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 26 quarters.
  • American International Group's Adverum Biotechnologies position peaked at $933K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.